Arbutus Biopharma (ABUS) Total Liabilities (2010 - 2026)
Arbutus Biopharma (ABUS) posted Total Liabilities of $17.0 million for Q1 2026, down 5.85% sequentially from $18.0 million in Q4 2025, and down 55.12% YoY from $37.9 million in Q1 2025.
Arbutus Biopharma (ABUS) Total Liabilities (2010 - 2026) Analysis & Trends
Arbutus Biopharma has reported Total Liabilities for 17 years, with the latest figure at $17.0 million in Q1 2026.
- Quarterly Total Liabilities fell 55.12% year-over-year to $17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (down 55.12% YoY) and the FY2025 annual result came in at $18.0 million, down 47.46% from the prior year.
- Total Liabilities declined to $17.0 million in Q1 2026 per ABUS's latest filing, from $18.0 million in the prior quarter.
- Over five years, Total Liabilities peaked at $71.0 million in Q1 2022 and troughed at $17.0 million in Q1 2026.
- A 5-year average of $39.5 million and a median of $37.9 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities surged 121.35% in 2022, then slumped 55.12% in 2026.
- Over 5 years, Total Liabilities stood at $58.6 million in 2022, then sank by 34.46% to $38.4 million in 2023, then retreated by 10.53% to $34.3 million in 2024, then plunged by 47.46% to $18.0 million in 2025, then decreased by 5.85% to $17.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $17.0 million, $18.0 million, and $20.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | 15.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.29 Mn |
| Mar 31, 2026 | 16.99 Mn |
| Dec 31, 2025 | 18.04 Mn |
| Sep 30, 2025 | 20.31 Mn |
| Jun 30, 2025 | 20.29 Mn |
| Mar 31, 2025 | 37.85 Mn |
| Dec 31, 2024 | 34.34 Mn |
| Sep 30, 2024 | 33.55 Mn |
| Jun 30, 2024 | 37.59 Mn |
| Mar 31, 2024 | 35.65 Mn |
| Dec 31, 2023 | 38.38 Mn |
| Sep 30, 2023 | 39.30 Mn |
| Jun 30, 2023 | 42.13 Mn |
| Mar 31, 2023 | 47.31 Mn |
| Dec 31, 2022 | 58.57 Mn |
| Sep 30, 2022 | 58.28 Mn |
| Jun 30, 2022 | 62.69 Mn |
| Mar 31, 2022 | 71.03 Mn |
| Dec 31, 2021 | 35.05 Mn |
| Sep 30, 2021 | 35.46 Mn |